100 related articles for article (PubMed ID: 37424369)
1. MEDIATE - Molecular DockIng at homE: Turning collaborative simulations into therapeutic solutions.
Vistoli G; Manelfi C; Talarico C; Fava A; Warshel A; Tetko IV; Apostolov R; Ye Y; Latini C; Ficarelli F; Palermo G; Gadioli D; Vitali E; Varriale G; Pisapia V; Scaturro M; Coletti S; Gregori D; Gruffat D; Leija E; Hessenauer S; Delbianco A; Allegretti M; Beccari AR
Expert Opin Drug Discov; 2023; 18(8):821-833. PubMed ID: 37424369
[TBL] [Abstract][Full Text] [Related]
2. Target Prediction by Multiple Virtual Screenings: Analyzing the SARS-CoV-2 Phenotypic Screening by the Docking Simulations Submitted to the MEDIATE Initiative.
Gervasoni S; Manelfi C; Adobati S; Talarico C; Biswas AD; Pedretti A; Vistoli G; Beccari AR
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203621
[TBL] [Abstract][Full Text] [Related]
3. Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.
Manelfi C; Gossen J; Gervasoni S; Talarico C; Albani S; Philipp BJ; Musiani F; Vistoli G; Rossetti G; Beccari AR; Pedretti A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33557115
[TBL] [Abstract][Full Text] [Related]
4. Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study.
Llanos MA; Gantner ME; Rodriguez S; Alberca LN; Bellera CL; Talevi A; Gavernet L
J Chem Inf Model; 2021 Aug; 61(8):3758-3770. PubMed ID: 34313128
[TBL] [Abstract][Full Text] [Related]
5. Advances in the discovery of new chemotypes through ultra-large library docking.
Potlitz F; Link A; Schulig L
Expert Opin Drug Discov; 2023 Mar; 18(3):303-313. PubMed ID: 36714919
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.
Mslati H; Gentile F; Perez C; Cherkasov A
J Chem Inf Model; 2021 Aug; 61(8):3771-3788. PubMed ID: 34313439
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
Talluri S
Comb Chem High Throughput Screen; 2021; 24(5):716-728. PubMed ID: 32798373
[TBL] [Abstract][Full Text] [Related]
8. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
Ebrahimi M; Karami L; Alijanianzadeh M
Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
[TBL] [Abstract][Full Text] [Related]
9. Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
Li Z; Li X; Huang YY; Wu Y; Liu R; Zhou L; Lin Y; Wu D; Zhang L; Liu H; Xu X; Yu K; Zhang Y; Cui J; Zhan CG; Wang X; Luo HB
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27381-27387. PubMed ID: 33051297
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
11. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
12. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
[TBL] [Abstract][Full Text] [Related]
13. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach.
Dhasmana A; Kashyap VK; Dhasmana S; Kotnala S; Haque S; Ashraf GM; Jaggi M; Yallapu MM; Chauhan SC
Curr Pharm Des; 2020; 26(41):5300-5309. PubMed ID: 32867645
[TBL] [Abstract][Full Text] [Related]
15. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
16. Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies.
Kumar S; Sharma PP; Upadhyay C; Kempaiah P; Rathi B; Poonam
Methods; 2021 Nov; 195():44-56. PubMed ID: 33639316
[TBL] [Abstract][Full Text] [Related]
17.
Mateev E; Georgieva M; Zlatkov A
Comb Chem High Throughput Screen; 2023; 26(6):1242-1250. PubMed ID: 35984023
[TBL] [Abstract][Full Text] [Related]
18. Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches.
Bhowmick S; Saha A; AlFaris NA; ALTamimi JZ; ALOthman ZA; Aldayel TS; Wabaidur SM; Islam MA
J Mol Graph Model; 2022 Mar; 111():108113. PubMed ID: 34959151
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
Tsuji M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
[TBL] [Abstract][Full Text] [Related]
20. Identification of SARS-CoV-2 main protease inhibitors from FDA-approved drugs by artificial intelligence-supported activity prediction system.
Komatsu H; Tanaka T; Ye Z; Ikeda K; Matsuzaki T; Yasugi M; Hosoda M
J Biomol Struct Dyn; 2023 Mar; 41(5):1767-1775. PubMed ID: 34984963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
